Back to GetFilings.com



Table of Contents



UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


Form 10-Q

     
(Mark One)    
þ   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
    For the quarterly period ended March 30, 2003
 
or
 
o   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number 1-5075


PerkinElmer, Inc.

(Exact Name Of Registrant As Specified In Its Charter)
     
Massachusetts   04-2052042
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. employer identification no.)
 
45 William Street,
Wellesley, Massachusetts
(Address of principal executive offices)
  02481
(Zip Code)

(781) 237-5100

(Registrant’s telephone number, including area code)

NONE

(Former name, former address and former fiscal year, if changed since last report)

     Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     Yes þ          No o

      Indicate by check whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).     Yes x          No o

      Number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:

     
Class Outstanding at May 9, 2003


Common Stock, $1 par value   126,111,865
    (Excluding treasury shares)




TABLE OF CONTENTS

PART I. FINANCIAL INFORMATION
Item 1. Financial Statements
PERKINELMER, INC. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS
CONSOLIDATED STATEMENTS OF CASH FLOWS
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Acquisitions and Divestitures
Formation of Our Life and Analytical Sciences Business
Discussion of Consolidated Results of Continuing Operations
Reporting Segment Results of Continuing Operations
Liquidity and Capital Resources
Critical Accounting Policies, Commitments and Certain Other Matters
Forward-Looking Information and Factors Affecting Future Performance
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Item 4. Controls and Procedures
PART II. OTHER INFORMATION
Item 4. Submission of Matters to a Vote of Security Holders
Item 6. Exhibits and Reports on Form 8-K
SIGNATURE
CERTIFICATIONS
EXHIBIT INDEX
EX-99.1 SECTION 906 CERTIFICATION


Table of Contents

TABLE OF CONTENTS

             
Page

PART I.  FINANCIAL INFORMATION
Item 1.
  Financial Statements     2  
    Consolidated Income Statements     2  
    Consolidated Balance Sheets     3  
    Consolidated Statements of Cash Flows     4  
    Notes to Consolidated Financial Statements     5  
Item 2.
  Management’s Discussion and Analysis of Financial Condition and Results of Operations     19  
    Acquisitions and Divestitures     19  
    Formation of Our Life and Analytical Sciences Business     19  
    Discussion of Consolidated Results of Continuing Operations     19  
    Reporting Segment Results of Continuing Operations     21  
    Liquidity and Capital Resources     22  
    Critical Accounting Policies, Commitments and Certain Other Matters     24  
    Forward-Looking Information and Factors Affecting Future Performance     25  
Item 3.
  Quantitative and Qualitative Disclosures About Market Risk     31  
Item 4.
  Controls and Procedures     32  
PART II.  OTHER INFORMATION
Item 4.
  Submission of Matters to a Vote of Security Holders     32  
Item 6.
  Exhibits and Reports on Form 8-K     33  
SIGNATURE     34  
CERTIFICATIONS     35  
EXHIBIT INDEX     37  
EX-99.1 Section 906 Certification        

1


Table of Contents

PART I.     FINANCIAL INFORMATION

Item 1.     Financial Statements

PERKINELMER, INC. AND SUBSIDIARIES

CONSOLIDATED INCOME STATEMENTS

                   
Three Months Ended

March 30, March 31,
2003 2002


(In thousands except
per share data)
(Unaudited)
Sales
  $ 358,449     $ 346,293  
Cost of sales
    219,280       220,563  
Research and development expenses
    20,852       21,807  
Selling, general and administrative expenses
    92,879       107,720  
Restructuring charges, net
    (445 )     9,224  
Gains on dispositions
    (580 )     (5,216 )
Amortization of intangible assets
    7,195       7,092  
     
     
 
Operating income (loss) from continuing operations
    19,268       (14,897 )
Other expense, net
    14,347       13,628  
     
     
 
Income (loss) from continuing operations before income taxes
    4,921       (28,525 )
Provision (benefit) for income taxes
    1,599       (7,866 )
     
     
 
Income (loss) from continuing operations
    3,322       (20,659 )
Loss from discontinued operations, net of income taxes
    (960 )     (8,901 )
     
     
 
Net income (loss) before effect of accounting change
    2,362       (29,560 )
Effect of accounting change, net of income taxes
          (117,800 )
     
     
 
Net income (loss)
  $ 2,362     $ (147,360 )
     
     
 
Basic and diluted earnings (loss) per share:
               
 
Continuing operations
  $ 0.03     $ (0.17 )
 
Loss from discontinued operations, net of income taxes
    (0.01 )     (0.07 )
     
     
 
 
Net income (loss) before effect of accounting change
    0.02       (0.24 )
 
Effect of accounting change, net of income tax
          (0.94 )
     
     
 
 
Net income (loss)
  $ 0.02     $ (1.18 )
     
     
 
Weighted average shares of common stock outstanding:
               
 
Basic
    125,649       124,864  
 
Diluted
    126,375       124,864  
Cash dividends per common share
  $ 0.07     $ 0.07  

The accompanying unaudited notes are an integral part of these consolidated financial statements.

2


Table of Contents

PERKINELMER, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

                     
March 30, December 29,
2003 2002


(Unaudited)
(In thousands except
share and per share data)
Current assets:
               
 
Cash and cash equivalents
  $ 129,777     $ 130,615  
 
Cash held in escrow
    154,463       186,483  
 
Accounts receivable, net
    272,070       304,647  
 
Inventories
    205,543       205,455  
 
Other current assets
    154,432       152,137  
 
Current assets of discontinued operations
    12,030       12,006  
     
     
 
   
Total current assets
    928,315       991,343  
     
     
 
Property, plant and equipment:
               
 
At cost
    606,406       598,048  
 
Accumulated depreciation
    (308,100 )     (294,026 )
     
     
 
Net property, plant and equipment
    298,306       304,022  
Investments
    12,999       14,298  
Intangible assets
    1,435,466       1,439,774  
Other assets
    74,125       83,835  
Long-term assets of discontinued operations
    3,523       2,967  
     
     
 
   
Total assets
  $ 2,752,734     $ 2,836,239  
     
     
 
Current liabilities:
               
 
Short-term debt
  $ 161,066     $ 191,491  
 
Accounts payable
    132,683       146,290  
 
Accrued restructuring costs and integration costs
    36,057       40,748  
 
Accrued expenses
    296,522       316,427  
 
Current liabilities of discontinued operations
    1,165       2,718  
     
     
 
   
Total current liabilities
    627,493       697,674  
Long-term debt
    599,272       614,053  
Long-term liabilities
    265,342       270,031  
Long-term liabilities of discontinued operations
    2,068       2,137  
Commitments and contingencies
               
Stockholders’ equity:
               
 
Preferred stock — $1 par value, authorized 1,000,000 shares; none issued or outstanding
           
 
Common stock — $1 par value, authorized 300,000,000 shares; issued 145,101,000 shares; and 126,089,000 and 125,854,000 outstanding at March 30, 2003 and December 29, 2002
    145,101       145,101  
 
Capital in excess of par value
    679,921       679,929  
 
Unearned compensation
    (5,190 )     (5,890 )
 
Retained earnings
    648,595       655,066  
 
Accumulated other comprehensive loss
    (20,211 )     (31,865 )
 
Cost of shares held in treasury — 19,261,000 shares at March 30, 2003 and 19,247,000 shares at December 29, 2002
    (189,657 )     (189,997 )
     
     
 
   
Total stockholders’ equity
    1,258,559       1,252,344  
     
     
 
   
Total liabilities and stockholders’ equity
  $ 2,752,734     $ 2,836,239  
     
     
 

The accompanying unaudited notes are an integral part of these consolidated financial statements.

3


Table of Contents

PERKINELMER, INC. AND SUBSIDIARIES

 
CONSOLIDATED STATEMENTS OF CASH FLOWS
                   
Three Months Ended

March 30, March 31,
2003 2002


(In thousands)
(Unaudited)
Operating activities:
               
Net income (loss)
  $ 2,362     $ (147,360 )
Add net loss from discontinued operations
    960       8,901  
Add effect of accounting change, net of income taxes
          117,800  
     
     
 
Income (loss) from continuing operations
    3,322       (20,659 )
Adjustments to reconcile net income (loss) from continuing operations to net cash provided by (used) in continuing operations:
               
Stock-based compensation
    700       1,203  
Amortization of debt discount and issuance costs
    2,354       5,216  
Depreciation and amortization
    18,801       19,192  
Gains on dispositions and sales of investments, net
    (580 )     (5,109 )
Changes in operating assets and liabilities which provided (used) cash, excluding effects from companies purchased and divested:
               
 
Accounts receivable
    37,342       17,527  
 
Inventories
    1,406       14,764  
 
Accounts payable
    (14,710 )     1,187  
 
Accrued restructuring costs
    (4,557 )     (23,047 )
 
Accrued expenses and other
    (21,173 )     (44,401 )
     
     
 
Net cash provided by (used in) operating activities from continuing operations
    22,905       (34,127 )
Net cash provided by operating activities from discontinued operations
    1,164       3,039  
     
     
 
Net cash provided by (used in) operating activities
    24,069       (31,088 )
Investing activities:
               
 
Cash withdrawn from escrow to repay debt
    32,509        
 
Capital expenditures
    (3,461 )     (16,525 )
 
Proceeds from dispositions of property, plant and equipment, net
          19,455  
 
Settlement of disposition of businesses, net
    (575 )     (2,397 )
 
Proceeds (cost) of acquisitions, net of cash acquired
    2,126       (17,480 )
 
Proceeds from sale of investments
          1,709  
     
     
 
Net cash provided by (used in) investing activities from continuing operations
    30,599       (15,238 )
Net cash used in investing activities from discontinued operations
          (3,570 )
     
     
 
Net cash provided by (used in) investing activities
    30,599       (18,808 )
Financing activities:
               
 
Payment of debt issuance costs
    (1,356 )      
 
Prepayment of zero coupon convertible notes
    (32,509 )      
 
Prepayment of term loan debt
    (15,000 )      
 
Prepayment of short-term debt
          (123,683 )
 
Increase in commercial paper borrowings
          219,000  
 
Increase (decrease) in other credit facilities
    211       (4,996 )
 
Proceeds from issuance of common stock
          6,674  
 
Purchases of common stock
          (5,804 )
 
Cash dividends
    (8,833 )     (8,793 )
     
     
 
Net cash (used in) provided by financing activities
    (57,487 )     82,398  
     
     
 
Effect of exchange rate changes on cash and cash equivalents
    1,981       (311 )
     
     
 
Net (decrease) increase in cash and cash equivalents
    (838 )     32,191  
Cash and cash equivalents at beginning of period
    130,615       138,250  
     
     
 
Cash and cash equivalents at end of period
  $ 129,777     $ 170,441  
     
     
 

The accompanying unaudited notes are an integral part of these consolidated financial statements.

4


Table of Contents

PERKINELMER, INC. AND SUBSIDIARIES

 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

(1) Basis of Presentation

      The consolidated financial statements included herein have been prepared by PerkinElmer, Inc. (the “Company”), without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information in footnote disclosures normally included in financial statements has been condensed or omitted in accordance with the rules and regulations of the SEC. These statements should be read in conjunction with the Company’s Annual Report for the fiscal year ended December 29, 2002, filed on Form 10-K with the SEC (the “2002 Form 10-K”). The balance sheet amounts at December 29, 2002 in this report were extracted from the Company’s audited 2002 financial statements included in the 2002 Form 10-K. Certain prior period amounts have been reclassified to conform to the current-year financial statement presentation. The information reflects all adjustments that, in the opinion of management, are necessary to present fairly the Company’s results of operations, financial position and cash flows for the periods indicated. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The results of operations for the three months ended March 30, 2003 and March 31, 2002 are not necessarily indicative of the results for the entire fiscal year.

(2) Gains on Dispositions

      During the first quarter of 2003, the Company recognized a $0.3 million net gain from the sale of a building, and a previously deferred $0.3 million gain from the sale of a business. During the first quarter of 2002, the Company sold three buildings that resulted in a net gain of $4.4 million on proceeds received of approximately $19.5 million and recognized $0.8 million in gains from a sale that was previously deferred.

(3) Restructuring Charges

      As discussed more fully in the Company’s 2002 Form 10-K, the Company has undertaken a series of restructuring actions. The principal actions associated with these plans related to a workforce reduction and overhead reductions resulting from continued reorganization activities, including the closure of certain manufacturing and selling facilities. Details of these plans are discussed more fully in the Company’s 2002 Form 10-K.

5


Table of Contents

PERKINELMER, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

      The following table summarizes the components of the Company’s restructuring plans and related accrual activity recorded for the quarter ended March 30, 2003.

                                           
Abandonment
of Excess Total Cash Asset
Severance Facilities Charges Writedown Total





(In thousands)
2001 Restructuring Plans
                                       
 
Balance at December 29, 2002
  $ 3,975     $ 100     $ 4,075     $     $ 4,075  
 
Amounts paid or incurred
    (1,274 )     (47 )     (1,321 )     (54 )     (1,375 )
 
Changes in estimates
    (645 )           (645 )           (645 )
     
     
     
     
     
 
 
Balance at March 30, 2003
    2,056       53       2,109       (54 )     2,055  
2002 Restructuring Plans